{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:48:21Z","timestamp":1779346101363,"version":"3.51.4"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272272"],"award-info":[{"award-number":["82272272"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.phrs.2025.107961","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:12:35Z","timestamp":1758589955000},"page":"107961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Selective thrombolysis through fibrin network destabilization: An unrecognized heparin analog mechanism"],"prefix":"10.1016","volume":"221","author":[{"given":"Ning","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shule","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8814-9103","authenticated-orcid":false,"given":"Jianfa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.107961_bib1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1160\/TH16-10-0823","article-title":"Venous thromboembolism: past, present and future","volume":"117","author":"Schulman","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2025.107961_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4062\/biomolther.2016.271","article-title":"New anticoagulants for the prevention and treatment of venous thromboembolism","volume":"25","author":"Kim","year":"2017","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.phrs.2025.107961_bib3","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jacc.2016.01.072","article-title":"Treatment of venous thromboembolism with new anticoagulant agents","volume":"67","author":"Becattini","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2025.107961_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.108.162677","article-title":"New anticoagulants for treatment of venous thromboembolism","author":"Gross","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2025.107961_bib5","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/jth.13524","article-title":"The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study","volume":"14","author":"Kyrle","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.phrs.2025.107961_bib6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ejim.2012.10.001","article-title":"New anticoagulants for treatment of venous thromboembolism","volume":"23","author":"Franchini","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.phrs.2025.107961_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra0907731","article-title":"Acute pulmonary embolism","volume":"363","author":"Agnelli","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2025.107961_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev-biophys-111821-072110","article-title":"Nanomechanics of blood clot and thrombus formation","volume":"51","author":"Domingues","year":"2022","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.phrs.2025.107961_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1023\/A:1013089924994","article-title":"New anticoagulant drugs","volume":"12","author":"Weitz","year":"2001","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.phrs.2025.107961_bib10","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1182\/blood.V75.7.1396.1396","article-title":"Antithrombotic effect of recombinant human thrombomodulin on Thrombin-Induced thromboembolism in mice","volume":"75","author":"Gomi","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2025.107961_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9545297","article-title":"Advances in chemical synthesis of fondaparinux","volume":"2019","author":"Ding","year":"2019","journal-title":"J. Chem."},{"key":"10.1016\/j.phrs.2025.107961_bib12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbrc.2022.03.005","article-title":"Schixator, a new FXa inhibitor from schistosoma japonicum with antithrombotic effect and low bleeding risk","volume":"603","author":"Ding","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2025.107961_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109097","article-title":"Anticoagulant therapy in renal insufficiency theme: anticoagulation in complex situations","volume":"241","author":"Parks","year":"2024","journal-title":"Thromb. Res."},{"key":"10.1016\/j.phrs.2025.107961_bib14","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.drudis.2020.09.011","article-title":"Advances in the preparation and synthesis of heparin and related products","volume":"25","author":"Baytas","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2025.107961_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11739-008-0164-9","article-title":"Low-molecular-weight heparin in patients with chronic renal insufficiency","volume":"3","author":"Lim","year":"2008","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.phrs.2025.107961_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122782","article-title":"Preparation and structural characterization of a sulfated octasaccharide with heparin-like anticoagulant activity","volume":"347","author":"Yu","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2025.107961_bib17","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1016\/j.biomaterials.2010.01.038","article-title":"Reconstruction of goat tibial defects using an injectable tricalcium phosphate\/chitosan in combination with autologous platelet-rich plasma","volume":"31","author":"Bi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2025.107961_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz9014","article-title":"Platelet-derived porous nanomotor for thrombus therapy","volume":"6","author":"Wan","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2025.107961_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.carbpol.2016.06.106","article-title":"Antithrombotic activities of fucosylated chondroitin sulfates and their depolymerized fragments from two sea cucumbers","volume":"152","author":"Liu","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2025.107961_bib20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.carbpol.2017.07.009","article-title":"Sulfated polysaccharide from cyclocarya paliurus enhances the immunomodulatory activity of macrophages","volume":"174","author":"Yu","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2025.107961_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00018-022-04257-7","article-title":"Novel contact\u2013kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke","volume":"79","author":"Zhang","year":"2022","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.phrs.2025.107961_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan5954","article-title":"Synthetic oligosaccharides can replace animal-sourced low\u2013molecular weight heparins","volume":"9","author":"Xu","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2025.107961_bib24","article-title":"Management of non-compressible hemorrhage and re-bleeding by a liquid hemostatic polysaccharide floccuronic acid","volume":"257","author":"Chen","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2025.107961_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.carbpol.2016.06.106","article-title":"Antithrombotic activities of fucosylated chondroitin sulfates and their depolymerized fragments from two sea cucumbers","volume":"152","author":"Liu","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2025.107961_bib26","article-title":"A MOF-based nanobomb for tumor microvascular occlusion and combined tumor starvation therapy and chemotherapy","volume":"24","author":"Liu","year":"2023","journal-title":"Mater. Today Nano"},{"key":"10.1016\/j.phrs.2025.107961_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/CIRCRESAHA.120.317245","article-title":"Identification and characterization of Plasmin-Independent thrombolytic enzymes","volume":"128","author":"Hassan","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2025.107961_bib28","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1182\/blood-2013-08-523860","article-title":"Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin","volume":"123","author":"Cines","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2025.107961_bib29","first-page":"297","article-title":"Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition","volume":"86","author":"Momi","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.phrs.2025.107961_bib30","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1111\/jth.15510","article-title":"Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism risk","volume":"19","author":"Kattula","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.phrs.2025.107961_bib31","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1476-5381.1993.tb14002.x","article-title":"The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits","volume":"110","author":"Paul","year":"1993","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107961_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1538-7836.2011.04615.x","article-title":"in vivo monitoring of venous thrombosis in mice","volume":"10","author":"Aghourian","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.phrs.2025.107961_bib33","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1111\/bph.13885","article-title":"The saponin D39 blocks dissociation of non-muscular myosin heavy chain IIA from TNF receptor 2, suppressing tissue factor expression and venous thrombosis","volume":"174","author":"Zhai","year":"2017","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107961_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.phrs.2016.04.001","article-title":"Role of thromboxane-dependent platelet activation in venous thrombosis: aspirin effects in mouse model","volume":"107","author":"Tarantino","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2025.107961_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijbiomac.2020.01.098","article-title":"Characterisation of the binding of dihydro-alpha-lipoic acid to fibrinogen and the effects on fibrinogen oxidation and fibrin formation","volume":"147","author":"Gligorijevi\u0107","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2025.107961_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijbiomac.2019.01.124","article-title":"Characterisation and the effects of bilirubin binding to human fibrinogen","volume":"128","author":"Gligorijevi\u0107","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2025.107961_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110535","article-title":"Arctigenin attenuates platelet activation and clot retraction by regulation of thromboxane A2 synthesis and cAMP pathway","volume":"130","author":"Nam","year":"2020","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2025.107961_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.trsl.2016.06.009","article-title":"Heparin-binding copolymer reverses effects of unfractionated heparin, enoxaparin, and fondaparinux in rats and mice","volume":"177","author":"Kalaska","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.phrs.2025.107961_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202200549","article-title":"Porous polymers as universal reversal agents for heparin anticoagulants through an Inclusion\u2013Sequestration mechanism","volume":"34","author":"Lin","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2025.107961_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/j.jvca.2003.10.021","article-title":"Heparin is much more than just an anticoagulant","volume":"18","author":"Day","year":"2004","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.phrs.2025.107961_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0049-3848(98)00213-8","article-title":"Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat","volume":"94","author":"Elg","year":"1999","journal-title":"Thromb. Res."},{"key":"10.1016\/j.phrs.2025.107961_bib42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.carbpol.2013.08.074","article-title":"Mapping of low molecular weight heparins using reversed phase ion pair liquid chromatography\u2013mass spectrometry","volume":"99","author":"Li","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2025.107961_bib43","series-title":"in: Prog. Mol. Biol. Transl. Sci.","first-page":"41","article-title":"The clinical use of fondaparinux: a synthetic heparin pentasaccharide","author":"Zhang","year":"2019"},{"key":"10.1016\/j.phrs.2025.107961_bib44","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1161\/ATVBAHA.117.308564","article-title":"Fibrinogen and fibrin in hemostasis and thrombosis","volume":"37","author":"Kattula","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2025.107961_bib45","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/pgmj.2007.059188","article-title":"Heparin induced thrombocytopenia: diagnosis and management update","volume":"83","author":"Ahmed","year":"2007","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.phrs.2025.107961_bib46","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/jth.13312","article-title":"The design and synthesis of new synthetic low-molecular-weight heparins","volume":"14","author":"Chandarajoti","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.phrs.2025.107961_bib47","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1055\/s-0040-1715460","article-title":"The anticoagulant and nonanticoagulant properties of heparin","volume":"120","author":"Beurskens","year":"2020","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2025.107961_bib48","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nature06797","article-title":"Triggers, targets and treatments for thrombosis","volume":"451","author":"Mackman","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107961_bib49","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jvsv.2020.09.008","article-title":"Management of inferior vena cava thrombosis with the FlowTriever and ClotTriever systems","volume":"9","author":"Shah","year":"2021","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"key":"10.1016\/j.phrs.2025.107961_bib50","doi-asserted-by":"crossref","DOI":"10.1161\/01.STR.0000200560.01068.65","article-title":"Thrombolytics, anticoagulants, and antiplatelet agents","author":"Ringleb","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2025.107961_bib51","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/bloodadvances.2019001299","article-title":"Passively transferred IgG enhances humoral immunity to a red blood cell alloantigen in mice","volume":"4","author":"Gruber","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.phrs.2025.107961_bib52","unstructured":"2025, Structure of fibrin: impact on clot stability - WEISEL - 2007 - Journal of Thrombosis and Haemostasis - Wiley Online Library, (n.d.). https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/j.1538\u20137836.2007.02504."},{"key":"10.1016\/j.phrs.2025.107961_bib53","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.120.315754","article-title":"Thrombus structural composition in cardiovascular disease","author":"Alkarithi","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2025.107961_bib54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0741-5214(95)70045-5","article-title":"Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis","volume":"22","author":"Ouriel","year":"1995","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.phrs.2025.107961_bib55","first-page":"430","article-title":"A pilot study of Pro-Urokinase in the treatment of deep vein thrombosis","volume":"72","author":"Mola","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2025.107961_bib56","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0021-9258(19)45531-2","article-title":"Mechanism of activation of human plasminogen by streptokinase: PRESENCE OF ACTIVE CENTER IN STREPTOKINASE-PLASMINOGEN COMPLEX","volume":"247","author":"Reddy","year":"1972","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.107961_bib57","series-title":"in: Ind. Appl. Microb. Enzym","article-title":"Role of streptokinase as a thrombolytic agent for medical applications","author":"Rafeeq","year":"2022"},{"key":"10.1016\/j.phrs.2025.107961_bib58","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1074\/jbc.273.5.3110","article-title":"Plasminogen activation by streptokinase via a unique mechanism","volume":"273","author":"Young","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.107961_bib59","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028056","article-title":"P. D\u2019Orl\u00e9ans-Juste, Chymase inhibition resolves and prevents deep vein thrombosis without increasing bleeding time in the mouse model","author":"Lapointe","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2025.107961_bib60","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1160\/TH14-10-0880","article-title":"NMMHC IIA inhibition impedes tissue factor expression and venous thrombosis via Akt\/GSK3\u03b2-NF-\u03baB signalling pathways in the endothelium","volume":"114","author":"Zhai","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2025.107961_bib61","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/ATVBAHA.118.312130","article-title":"Intrinsic pathway of coagulation and thrombosis","volume":"39","author":"Grover","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2025.107961_bib62","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bcmd.2005.12.014","article-title":"The intrinsic pathway of coagulation is essential for thrombus stability in mice","volume":"36","author":"Renn\u00e9","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.phrs.2025.107961_bib63","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1538-7836.2005.01128.x","article-title":"Initiation and propagation of coagulation from tissue factor-bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate","volume":"3","author":"Ovanesov","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.phrs.2025.107961_bib64","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1161\/ATVBAHA.107.155952","article-title":"T. Renn\u00e9, Intrinsic pathway of coagulation and arterial thrombosis","volume":"27","author":"Gailani","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2025.107961_bib65","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nm.1955","article-title":"A shear gradient\u2013dependent platelet aggregation mechanism drives thrombus formation","volume":"15","author":"Nesbitt","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2025.107961_bib66","series-title":"in: Platelets","first-page":"371","article-title":"Hemostatic thrombus formation in flowing blood","author":"Brass","year":"2019"},{"key":"10.1016\/j.phrs.2025.107961_bib67","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.thromres.2014.03.017","article-title":"Fibrinogen and red blood cells in venous thrombosis","volume":"133","author":"Aleman","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.phrs.2025.107961_bib68","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1111\/jth.12918","article-title":"Fibrinogen, red blood cells, and factor XIII in venous thrombosis","volume":"13","author":"Walton","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.phrs.2025.107961_bib69","first-page":"340","article-title":"Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation","volume":"63","author":"Takahashi","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2025.107961_bib70","doi-asserted-by":"crossref","DOI":"10.2147\/VHRM.S138890","article-title":"Reversal of direct oral anticoagulants","author":"Almegren","year":"2017","journal-title":"Vasc. Health Risk Manag"},{"key":"10.1016\/j.phrs.2025.107961_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1352982","article-title":"Unlocking the potential of fondaparinux: guideline for optimal usage and clinical suggestions (2023)","volume":"15","author":"Yin","year":"2024","journal-title":"Front. Pharm."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182500386X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182500386X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:08:08Z","timestamp":1773126488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366182500386X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":70,"alternative-id":["S104366182500386X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107961","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective thrombolysis through fibrin network destabilization: An unrecognized heparin analog mechanism","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107961"}}